Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery
Clinical trial NCT02893930 · COMPLETED
Trial details
- NCT number
- NCT02893930
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-28
- Primary completion
- 2021-05-11
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.